GC
COYA icon

Greenlight Capital’s Coya Therapeutics COYA Stock Holding History

Greenlight Capital’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$9.44M Buy
1,274,026
+805,959
+172% +$4.47M 0.46% 27
2023
Q3 		$1.8M Buy
468,067
+75,420
+19% +$300K 0.1% 31
2023
Q2 		$1.6M Hold
392,647
– – 0.07% 32
2023
Q1 		$1.56M Buy
392,647
+203
+0.1% +$887 0.08% 31
2022
Q4 		$1.86M Buy
+392,444
New +$1.83M 0.13% 29

Other funds holding COYA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Greenlight Capital's COYA Position: Q4 2023 in Review

Greenlight Capital increased its Coya Therapeutics (COYA) stake by 172% in Q4 2023, buying an estimated $4.47M and bringing the position to 1,274,026 shares worth $9.44M. The position accounts for 0.46% of the portfolio, ranked #27.

Greenlight Capital first reported a position in COYA in Q4 2022 and has held it in 5 quarters since. 21 funds tracked by Wall St. Rank hold COYA as of Q4 2023.

  • Greenlight Capital held 1,274,026 shares of Coya Therapeutics worth $9.44M as of Q4 2023.
  • Greenlight Capital bought 805,959 Coya Therapeutics shares in Q4 2023, an estimated $4.47M.
  • Coya Therapeutics made up 0.46% of Greenlight Capital's portfolio in Q4 2023, its #27 holding.
  • Greenlight Capital first reported a position in Coya Therapeutics in Q4 2022 and has held it in 5 quarters since.
  • 21 funds tracked by Wall St. Rank held Coya Therapeutics as of Q4 2023.

Based on Greenlight Capital's 13F filing for Q4 2023, filed 14 Feb 2024.